Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
nothing has been published on the four together
SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance discovery of SAM-competitive PRMT5 inhibitor PF-06939999
For the survival study, animals were treated with i.p
Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, Lanzone A
Disclose all medications
US$ 22.35
US$ 24.63
US$ 29.77
US$ 23.28
US$ 26.76
US$ 29.17
US$ 28.01
US$ 20.62
US$ 22.62
US$ 20.82
